$65 million expansion to HPAPI manufacturing facility
The expansion will be specifically designed to manufacture high-potency active…
The expansion will be specifically designed to manufacture high-potency active pharmaceutical ingredients (HPAPIs) and complex antibody-drug conjugates (ADCs).